10.14.18

Gemini version available ♊︎

Court of Appeals for the Federal Circuit Decides That USPTO Wrongly Granted Patents to Roche

Posted in America, Courtroom, Patents at 10:22 am by Dr. Roy Schestowitz

Not just 35 U.S.C. § 101; nature is not an invention either

A stormy paradise

Summary: Patent quality issues at the U.S. Patent and Trademark Office (USPTO) — motivated by money rather than common sense — continue to be highlighted by courts; the USPTO needs to raise the bar to improve the legal certainty associated with US patents

THE USPTO isn’t exactly renowned for patent quality; it’s known as the ‘go-to office’ for quick and easy patents and it’s also known for its ridiculous number of patents (recently exceeded 10 million).

Suffice to say, the USPTO has granted grant many bogus patents or fake patents (ones that should never have been granted and have no legal standing in actual courts of law). Natural Alternatives International has decided to sue the USPTO for having invalidated its patent in a Patent Trial and Appeal Board (PTAB) inter partes review (IPR). Donald Zuhn wrote about it a few days ago. They’re suing the USPTO because it’s granting patents falsely and even its own staff admits that. It recently explained that such patents should not have been granted, leading to this suit:

Last week, in Natural Alternatives International, Inc. v. Iancu, the Federal Circuit affirmed a determination by the U.S. Patent and Trademark Office Patent Trial and Appeal Board in an inter partes reexamination affirming the Examiner’s rejection of the challenged claims of U.S. Patent No. 8,067,381 as being anticipated or obvious over the cited prior art, as well as the Board’s denial of the patentee’s request for rehearing. The ’381 patent is owned by Appellant Natural Alternatives International, Inc. (“NAI”).

The inter partes reexamination was requested by Woodbolt Distributors, LLC, which had been involved in district court litigation with NAI concerning the ’381 patent. In its request, Woodbolt asserted that the priority claim of the ’381 patent was defective because NAI “deliberately and expressly terminated” its claim to the benefit of the first four priority applications by breaking the chain of priority between the fourth and fifth priority applications.

Iancu ought to know that the only solution is for USPTO management (and in turn examiners) to raise examination standards.

More media attention has been dedicated to Swiss giant Roche. The Federal Circuit continues to ‘finish off’ bad patents that should never have been granted. It adds its weight to PTAB’s and Roche isn’t happy.

“The Federal Circuit on Tuesday upheld a ruling that a tuberculosis test patent Roche Molecular Systems Inc. asserted against Cepheid is invalid for claiming only natural phenomena,” Matthew Bultman wrote. Bultman is a patent maximalist.

Reuters’ Jan Wolfe, who is more impartial, wrote this:

A federal appeals court on Tuesday said a patent owned by Roche Molecular Systems Inc on a method of detecting tuberculosis should not have been granted, handing a win to rival diagnostics company Cepheid Inc.

Kevin Noonan, a proponent of patents on life, noted that “[t]he District Court granted summary judgment of invalidity for both types of claims for patent-ineligibility, and the Federal Circuit affirmed, in an opinion by Judge Reyna” (the one who patent maximalists like to mock). To quote:

This recognition significantly reduces the precedential effect of the BRCA1 decision and provides, perhaps, a way for a future panel to distinguish claims to primers from this precedent. Judge O’Malley reminds her colleagues and us that the BRCA1 decision did not rule on the patent eligibility of PCR primer claims and does not compel the result the Court announced here.

Judge O’Malley’s concurrence also notes that this case, unlike the BRCA1 case, contains unresolved questions of material fact that, while disregarded by the Court may provide another basis for distinguishing the BRCA1 decision. Citing the distinctions drawn by the Supreme Court in Myriad between genomic DNA and cDNA, Judge O’Malley opines that while the BRCA1 opinion sets forth the basis for finding the PCR primer claims to be patent ineligible, “it is not clear from the BRCA1 opinion or record why we reached this conclusion. The lack of record evidence underlying BRCA1′s conclusion on this point is important in light of the record in this case.” She then goes on to recite the factual distinctions argued by Roche regarding the differences between the claimed primers and the sequences as they occur in nature (including the differences in strandedness, complementarity (“a primer comprising a nucleotide sequence of ATCG is complementary to, but unquestionably different from, a natural DNA strand comprising a sequence of TAGC”), the presence of a 3′ hydroxyl group, the linearity of the primers versus the circular nature of bacterial DNA, and that natural “primers” comprise RNA and not DNA). All these facts were adduced from expert testimony and thus for Judge O’Malley raise “genuine issue of material fact” that are not appropriate for summary judgment. Judge O’Malley also notes that the claimed primers here have a markedly different function, unlike the genomic DNA in Myriad, due to the presence of the 3′ hydroxyl group which permits PCR amplification to occur. Judge O’Malley apprehends that the patentee in this case raised factual issues not addressed in the Court’s BRCA1 decision, and thus, “unlike the appellants in Myriad and in BRCA1, here, Roche submitted evidence of record that, at the very least, raises genuine issues of material fact as to whether there exists anything in nature that both has the structure and performs the function of the claimed primers.” Accordingly, she believes not only that the BRCA1 decision does not compel the Court’s conclusion here, but that the question should be taken up en banc to clarify the law regarding the patent eligibility of oligonucleotide primers and perhaps methods of using such primers to amplify targeted portions of DNA.

While this concurring opinion is a welcome ray of sunshine on a cloudy day, the practical effects of this, like so many Federal Circuit decisions on eligibility, is to incentive non-disclosure of inventions such as these, with the concomitant injury to progress that trade secret protection of diagnostic methods is almost certain to create. It should be self-evident that this outcome is contrary to the Constitutional mandate underlying the patent system, but it appears the current constitution of the Court is unconcerned with this outcome. Perhaps Chief Judge Woods of the Seventh Circuit was right after all.

What we have here isn’t an example of software patents and what’s noteworthy about it is that it demonstrates patent quality issues beyond the domain of software. The USPTO needs to think carefully how to better align with courts’ decisions rather than expect courts to bend in favour of Iancu’s “business model” — incidentally the subject of our next post.

Share in other sites/networks: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Reddit
  • email

Decor ᶃ Gemini Space

Below is a Web proxy. We recommend getting a Gemini client/browser.

Black/white/grey bullet button This post is also available in Gemini over at this address (requires a Gemini client/browser to open).

Decor ✐ Cross-references

Black/white/grey bullet button Pages that cross-reference this one, if any exist, are listed below or will be listed below over time.

Decor ▢ Respond and Discuss

Black/white/grey bullet button If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

DecorWhat Else is New


  1. IRC Proceedings: Tuesday, October 26, 2021

    IRC logs for Tuesday, October 26, 2021



  2. Beatriz Busaniche Speaks Up in Defense of Richard Stallman

    Beatriz Busaniche sent us this comment in July 2021. She wrote it originally in Spanish. Here are both the original text and our translation to English.



  3. Links 26/10/2021: SUSE Linux Enterprise Micro 5.1 and Multi-Distro Benchmarks

    Links for the day



  4. Links 26/10/2021: Vulkan 1.1 Conformance for Raspberry Pi 4 and Tor Browser 10.5.10

    Links for the day



  5. [Meme] Sounds Legit

    When not cheating on the wife, the EPO‘s “doyen” cheats in the exams and makes it into the epi Council, in effect working “[t]owards a common understanding [sic] of quality” with “patent attorneys nominated as “assessors” by the EPO, epi and BusinessEurope” (notorious lobbyists for dictators, litigation, and monopolies, neither business nor science)



  6. [Meme] Mayoral Patent Office Chief

    As it turns out, political 'double-dipping' isn't just a thing in North Macedonia, Austria, and EPOnia



  7. Romania's Patent Office (OSIM): Nine Different Chiefs in Just Eight Years

    The Romanian State Office for Inventions and Trademarks (OSIM), being the equivalent of the U.S. Patent and Trademark Office (USPTO) in the sense that it covers both patents and trademarks, is a very flaky institution with no shortage of scandals; for our English-reading audiences we now have a summary of a decade’s worth of blunders and leadership changes



  8. The EPO’s Overseer/Overseen Collusion — Part XXIV: The Balkan League - Romania

    Romania’s patent office has been in flux this past decade, occasionally led by people with no relevant experience, but rather political connections (like EPO President António Campinos) and sometimes forged documents and fake degrees



  9. IRC Proceedings: Monday, October 25, 2021

    IRC logs for Monday, October 25, 2021



  10. [Meme] “Social Democracy” at the EPO

    Some comments on the current situation at the European Patent Office from Goran Gerasimovski, the new EPO Administrative Council delegate for North Macedonia and Social Democratic candidate for mayor of Centar (a municipality of Skopje)



  11. [Meme] António Campinos Visits the OSIM

    António Campinos visits OSIM Director-General Ionel Muscalu in February 2014



  12. [Meme] [Teaser] Meet the President

    Later today we shall see what Romania did for Battistelli



  13. Links 26/10/2021: Latte Dock 0.10.3 and Linux 5.15 RC7

    Links for the day



  14. Gemini Protocol's Originator: “I Continue to Care About This Project and I Care About the Community That Has Formed Around It.”

    'Solderpunk' is back from a long hiatus; this bodes well for Geminispace, which grew fast in spite of the conspicuous absence



  15. Bulgarian Like Bavarian Serfdom

    Bulgarian politics seem to have played a big role in selecting chiefs and delegates who backed Benoît Battistelli‘s unlawful proposals, which treat workers almost like slaves and ordinary citizens as disposable ‘collaterals’



  16. The EPO’s Overseer/Overseen Collusion — Part XXIII: The Balkan League - Bulgaria

    Today we examine the role of Bulgaria in Benoît Battistelli‘s liberticidal regime at the EPO (as well as under António Campinos, from 2018 to present) with particular focus on political machinations



  17. Links 25/10/2021: New Slackware64-current and a Look at Ubuntu Budgie

    Links for the day



  18. Links 25/10/2021: pg_statement_rollback 1.3 and Lots of Patent Catchup

    Links for the day



  19. Microsoft GitHub Exposé — Part III — A Story of Plagiarism and Likely Securities Fraud

    Today we tread slowly and take another step ahead, revealing the nature of only some among many problems that GitHub and Microsoft are hiding from the general public (to the point of spiking media reports)



  20. [Meme] [Teaser] Oligarchs-Controlled Patent Offices With Media Connections That Cover Up Corruption

    As we shall see later today, the ‘underworld’ in Bulgaria played a role or pulled the strings of politically-appointed administrators who guarded Benoît Battistelli‘s liberticidal regime at the EPO



  21. IRC Proceedings: Sunday, October 24, 2021

    IRC logs for Sunday, October 24, 2021



  22. Links 25/10/2021: EasyOS 3.1 and Bareflank 3.0

    Links for the day



  23. The Demolition of the EPO Was Made Possible With Assistance From Countries That Barely Have European Patents

    The legal basis of today's EPO has been crushed; a lot of this was made possible by countries with barely any stakes in the outcome



  24. The EPO’s Overseer/Overseen Collusion — Part XXII: The Balkan League - North Macedonia and Albania

    We continue to look at Benoît Battistelli‘s enablers at the EPO



  25. Links 24/10/2021: GPS Daemon (GPSD) Bug and Lots of Openwashing

    Links for the day



  26. Links 24/10/2021: XWayland 21.1.3 and Ubuntu Linux 22.04 LTS Daily Build

    Links for the day



  27. IRC Proceedings: Saturday, October 23, 2021

    IRC logs for Saturday, October 23, 2021



  28. Links 24/10/2021: Ceph Boss Sage Weil Resigns and Many GPL Enforcement Stories

    Links for the day



  29. GAFAM-Funded NPR Reports That Facebook Let Millions of People Like Trump Flout the So-called Rules. Not Just “a Few”.

    Guest post by Ryan, reprinted with permission



  30. Some Memes About What Croatia Means to the European Patent Office

    Before we proceed to other countries in the region, let’s not forget or let’s immortalise the role played by Croatia in the EPO (memes are memorable)


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts